Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis
article
OA: bronze
CC0
⤵ 53 in-corpus citations
AI-generated summary
This study found that serum VEGF levels were not significantly different between endometriosis patients and controls, despite VEGF's known role in endometriotic lesion development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Elevated concentrations of vascular endothelial growth factor (VEGF) have been detected in the peritoneal fluid of patients with endometriosis. Furthermore, it was postulated that VEGF is involved in the development of endometriotic lesions. The present study is aimed at determining whether high levels of VEGF could also be found in the serum of patients with endometriosis. METHODS: VEGF levels were measured by enzyme-linked immunosorbent assay (ELISA) in serum from 131 subjects with surgically confirmed endometriosis and 146 controls with no clinical evidence of the disease or detectable endometriotic lesions at the time of surgical examination. Parameters such as demographics, personal habits, menstrual characteristics and clinical profile were collected from each subject included in this study. RESULTS: The mean VEGF levels were not significantly modulated in serum samples of cases compared with controls in a crude general linear model and in a model adjusted for possible confounders. VEGF serum levels did not correlate with the score, stage of endometriosis or the presence of benign gynaecological disorders. However, a correlation was found between circulating concentrations of VEGF and body mass index. CONCLUSION: Although VEGF seems to play a pivotal role locally in the implantation and development of endometriotic lesions, the disease is not associated with a significant modulation in the levels of circulating VEGF.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Angiogenesis and Macrophage Activation in Endometriosis via openalex
- Angiogenic activity of peritoneal fluid from women with endometriosis via openalex
- Angiogenic Factors in Endometriosis via openalex
- Behaviour of Cytokine Levels in Serum and Peritoneal Fluid of Women with Endometriosis via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex
- Menstrual Cycle Characteristics and the Risk of Endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- Regulation of angiogenesis in the endometrium via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Serum and peritoneal fluid levels of IGF I and II and insulinlike growth binding protein-3 in endometriosis. via openalex
- Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines via openalex
- The Epidemiology of Endometriosis via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- Tissue Inhibitor of Metalloproteinase-1 Concentrations are Attenuated in Peritoneal Fluid and Sera of Women with Endometriosis and Restored in Sera by Gonadotropin-Releasing Hormone Agonist Therapy via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- W1985959551 via openalex
- W1972238505 via openalex
- W2105669982 via openalex
- W2140246703 via openalex
- W2142285406 via openalex
- W2147624141 via openalex
- W2345696364 via openalex
- W2029598549 via openalex
- W2057684012 via openalex
- W1990692512 via openalex
- W1921041263 via openalex
- W2089788793 via openalex
Cited by (50)
- RETRACTED ARTICLE: Optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9 2024
- Predictive Value of Serum Vascular Endothelial Growth Factor Level for Postoperative Endometriosis Recurrence in Patients with Ovarian Endometriosis 2023
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Endometriosis through an immunological lens: a pathophysiology based in immune dysregulation 2022
- Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate 2021
- Inflammatory cytokine profile of VEGF and IL-6 from the endometrium of women with and without endometriosis 2021
- Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology–Based Identification 2020
- Comparison of Endoglin Levels (CD 105) in Women's Menstrual Blood Endometriosis and without Endometriosis 2020
- Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways 2019
- LINC01541 overexpression attenuates the 17β-Estradiol-induced migration and invasion capabilities of endometrial stromal cells 2019
- Analysis of menstrual effluent: diagnostic potential for endometriosis 2018
- Anti‐Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms 2018
- Vascular endothelial growth factor genetic polymorphisms at +405C/G and -460 C/T and the association with advanced stages of endometriosis 2018
- Angiogenesis y Endometriosis 2017
- Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study. 2016
- Role of angiogenesis in endometriosis 2016
- Vascular Endothelial Growth Factor Serum Levels in Women with Advanced Endometriosis 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- The effect of macrophages on fibroblast activity and lesion development in mouse models of endometriosis. 2014
- Clinical markers of endometriosis: Have we been too quick to judge? 2014
- Relation of peritoneal fluid and serum vascular endothelial growth factor levels to endometriosis stage 2014
- Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment 2013
- Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. 2013
- Serum cytokine and growth factor levels in patients with endometriosis 2013
- Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis. 2012
- Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis 2012
- Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis 2011
- Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis 2010
- Matrix Metalloproteinase-3 mRNA: A Promising Peripheral Blood Marker for Diagnosis of Endometriosis 2010
- Peripheral biomarkers of endometriosis: a systematic review 2010
- Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis 2009
- Interleukin-8 serum levels do not correlate with pelvic pain in patients with ovarian endometriomas 2009
- Expression and Role of Peptides, Proteins and Growth Factors in the Pathogenesis of Endometriosis 2009
- Expression and role of peptides, proteins and growth factors in the pathogenesis of endometriosis 2009
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis 2008
- Relationship between Microvascular Density and Expression of Vascular Endothelial Growth Factor in Patients with Ovarian Endometriosis 2008
- Concentrations of Receptor for Advanced Glycation End Products, VEGF and CML in Plasma, Follicular Fluid, and Peritoneal Fluid in Women With and Without Endometriosis 2008
- Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis 2007
- Angiogenesis and antiangiogenic therapy in endometriosis 2007
- Expressão gênica diferencial em tecido endometrial tópico e lesões endometrióticas 2007
- Immunological Aspects of Endometriosis 2007
- Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain 2007
- The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions 2006
- Apoptosis pattern in human endometrium in women with pelvic endometriosis 2006
- Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis 2006
- Identification of molecular markers for endometriosis in blood lymphocytes by using deoxyribonucleic acid microarrays 2006
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis 2005
- Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis 2005
- Concentrations of Alpha-Fetoprotein, Insulin-Like Growth Factor Binding Protein-3, c-erbB-2, and Epidermal Growth Factor in Serum of Patients With Endometriosis 2004
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:50.257867+00:00
License: CC0
· commercial use OK